Fraunhofer-Gesellschaft v HMD Global (CFI, 8 September 2025)
| Date | 8 September 2025 |
|---|---|
| Court | CFI |
| Division | Hamburg (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_34320/2025 · ORD_34616/2025 |
| Parties | HMD Global Oy |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 8 September 2025 (UPC_CFI_495/2025, App_34320/2025), the President of the Court of First Instance, after consulting the panel of the Hamburg Local Division, granted the application of HMD Global Oy, defendant to Fraunhofer-Gesellschaft’s infringement action on European patent EP 2 609 590, and changed the language of the proceedings from German to English, the language in which the patent was granted. The order follows the Court of Appeal’s approach: the defendant’s position carries particular weight, and a claimant used to working in English suffers no unfairness from proceedings in the language of the patent.
Question
Should the language of the proceedings be changed to English on grounds of fairness under Art. 49(5) UPCA, at the request of a Finnish defendant sued in German?
Decision
Yes. All relevant circumstances are weighed, with particular weight given to the defendant’s position. English is the language most commonly used in the technical field concerned (audio processing and decoding), which was not disputed. Even for a multinational company, the need to coordinate internally in its working language must be taken into account. Sued in German, the defendant would face significant time pressure and translation work. The claimant, a research institute active internationally, regularly communicates in English. The application, made before the statement of defence, would not delay the proceedings. No translation arrangements were required under Rule 324. The order may be appealed within 15 days.
Key points for practice
- Practical point: an application to change the language is best made early, before the statement of defence, and supported by evidence of the use of English in the technical field and of the defendant’s working language.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 49(1) and (5) and Art. 73(2)(a)
- Rules of Procedure
- Rules 220.1(c), 323 and 324
- Case law cited
- Curio Bioscience v 10x Genomics, Court of Appeal, 17 April 2024, Court of Appeal, 18 September 2024, UPC_CoA_354/2024
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantHMD Global Oy15 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- La langue de procédure est changée de l'allemand vers l'anglais, langue de délivrance du brevet, sans condition de traduction.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 609 590mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Fraunhofer-Gesellschaft v HMD Global (CFI, UPC_CFI_495/2025, 24 August 2026) cited in this record
- Curio Bioscience v 10x Genomics (CoA, 17 April 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 609 590 | Mentioned in the analysis (role not qualified) Also mentioned in 4 other decision(s): Fraunhofer-Gesellschaft v HMD Global (CFI, UPC_CFI_495/2025, 24 August · Fraunhofer-Gesellschaft v HMD Global (CFI, UPC_CFI_494/2025, 24 August · Fraunhofer-Gesellschaft v HMD Global (CFI, UPC_CFI_494/2025, 1 June 20 · Fraunhofer-Gesellschaft v HMD Global (CFI, 19 December 2025) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.